Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 63,107 shares at $15.28 ($100K) on 2020-03-25, disclosed to the SEC on 2020-03-26.
Open-market sale of $100k EPZM by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 56,537 | $0 | 0.0% |
| 2 | $15.28 | 3,285 | $50K | 50.0% |
| 3 | $15.28 | 3,285 | $50K | 50.0% |
| Total | $1.59 avg | 63,107 | $100K | 100% |
| Filing → |
| EPZM | SELL | 2021-02-05 | $44K | — | Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |